NeutraKine®IL-12 p35 Monoclonal antibody

NeutraKine®IL-12 p35 Monoclonal Antibody for ELISA, Neutralization

Host / Isotype

Mouse / IgG2b

Reactivity

Human

Applications

ELISA, Neutralization

Conjugate

Unconjugated

CloneNo.

2G11G6

Cat no : 69029-1-Ig

Print datasheet

Synonyms

CLMF, CLMF p35, IL 12 subunit p35, IL 12A, IL-12 p35, IL12A, Interleukin 12 subunit alpha, NFSK, NKSF1, P35



Neutralization

产品信息

69029-1-Ig targets NeutraKine®IL-12 p35 in ELISA, Neutralization applications and shows reactivity with Human samples.

Tested Applications ELISA, Neutralization Application Description
Tested Reactivity Human
Immunogen human HumankineIL-12 p35 protein HZ-1256 种属同源性预测
Host / Isotype Mouse / IgG2b
Class Monoclonal
Type Antibody
Full Name interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
Synonyms CLMF, CLMF p35, IL 12 subunit p35, IL 12A, IL-12 p35, IL12A, Interleukin 12 subunit alpha, NFSK, NKSF1, P35
Gene Symbol IL-12A
Gene ID (NCBI) 3592
Conjugate Unconjugated
Form Lyophilized Powder
Purification MethodProtein A purification
Storage Buffer Sterile PBS.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

背景介绍

IL-12 p35 is a subunit of a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. The cytokine is a disulfide-linked heterodimer composed of the 35-kD subunit encoded by this gene, and a 40-kD subunit that is a member of the cytokine receptor family. This cytokine is required for the T-cell-independent induction of IFN-gamma and is important for the differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of this cytokine in innate immunity.

This antibody can be used to neutralize the bioactivity of IL-12 p35.